Begin main content

Calls for Patient Input: Darunavir/cobicistat/emtricitabine/tenofovir alafenamide

Published on: November 24, 2017
Result type: News

CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website.

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide

Brand name Generic name Manufacturer Indication(s)
TBC Darunavir/cobicistat/emtricitabine/tenofovir alafenamide Janssen Inc. HIV-1 infection
Project Number Call for patient input Patient input deadline Submit patient input
SR0552-000 2017-11-24 2018-01-22 Submit